Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06755060Not ApplicableRecruiting

Ophthalmic AI-Assisted Medical Decision-Making

Role: collaborator

NCT06479304Not ApplicableRecruiting

The Efficacy and Safety of HCQ Plus Pred in ANA Positive ITP

Role: collaborator

NCT06479317Not ApplicableRecruiting

The Efficacy and Safety of HCQ Plus DEX in ANA Positive ITP

Role: collaborator

NCT06479291Not ApplicableRecruiting

The Efficacy and Safety of HCQ Plus TPO-RA in ANA Positive ITP

Role: collaborator

All 4 trials loaded